Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10789
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAzad, Arun Aen
dc.contributor.authorChong, Geoffreyen
dc.contributor.authorTauro, Aen
dc.contributor.authorAly, Ahmaden
dc.contributor.authorTebbutt, Niall Cen
dc.date.accessioned2015-05-16T00:21:18Z-
dc.date.available2015-05-16T00:21:18Z-
dc.date.issued2009-03-19en
dc.identifier.citationMedical Oncology (northwood, London, England) 2009; 27(2): 230-2en
dc.identifier.govdoc19296240en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10789en
dc.description.abstractWe present the case of a 65-year-old male with squamous cell carcinoma of the thoracic oesophagus on a background of neurofibromatosis type 1. On computed tomography, he was noted to have a large left-sided superior mediastinal mass. Initially, this mass was thought to be metastatic lymphadenopathy; however, it did not display fluorodeoxyglucose uptake on positron emission tomography. Subsequent biopsy confirmed the mass to be a neurofibroma and the patient commenced definitive chemo-radiation. Positron emission tomography had a major impact on management since the presumed lymph node disease was not included in the radiation field. In addition, positron emission tomography altered prognostic stratification since lymph node involvement is a poor prognostic factor in oesophageal cancer. We could only identify one other case in the English literature in which positron emission tomography was used to distinguish metastatic carcinoma from a neurofibroma, although there are a number of reports that describe the utility of positron emission tomography in differentiating benign neurofibromas from malignant connective tissue tumours.en
dc.language.isoenen
dc.subject.otherAgeden
dc.subject.otherDiagnosis, Differentialen
dc.subject.otherEsophageal Neoplasms.diagnosis.radionuclide imaging.secondaryen
dc.subject.otherFluorodeoxyglucose F18.diagnostic useen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherNeurofibroma.diagnosis.radionuclide imagingen
dc.subject.otherPositron-Emission Tomographyen
dc.title18F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma.en
dc.typeJournal Articleen
dc.identifier.journaltitleMedical oncology (Northwood, London, England)en
dc.identifier.affiliationLudwig Institute Oncology Unit, University of Melbourne, Austin Hospital, Austin Health, Heidelberg, Victoria, Australia, Australiaen
dc.identifier.doi10.1007/s12032-009-9196-xen
dc.description.pages230-2en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/19296240en
dc.type.austinJournal Articleen
local.name.researcherAly, Ahmad
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.grantfulltextopen-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptSurgery-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Files in This Item:
File SizeFormat 
19296240.pdf44.46 kBAdobe PDFView/Open
Show simple item record

Page view(s)

40
checked on Mar 28, 2024

Download(s)

60
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.